Cargando…
Transcriptional analysis identifies potential novel biomarkers associated with successful ex‐vivo perfusion of human donor lungs
BACKGROUND: Transplantation is an effective treatment for end‐stage lung disease, but the donor organ shortage is a major problem. Ex‐vivo lung perfusion (EVLP) of extended criteria organs enables functional assessment to facilitate clinical decision‐making around utilization, but the molecular proc...
Autores principales: | Ferdinand, John Robert, Morrison, Morvern Isabel, Andreasson, Anders, Charlton, Catriona, Chhatwal, Alisha Kaur, Scott, William Earl, Borthwick, Lee Anthony, Clatworthy, Menna Ruth, Fisher, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285052/ https://www.ncbi.nlm.nih.gov/pubmed/34954872 http://dx.doi.org/10.1111/ctr.14570 |
Ejemplares similares
-
Modeling the Effects of IL-1β-mediated Inflammation During Ex Vivo Lung Perfusion Using a Split Human Donor Model
por: Pither, Thomas, et al.
Publicado: (2023) -
Understanding the Immunology of Normothermic Machine Perfusion
por: Clatworthy, Menna Ruth, et al.
Publicado: (2023) -
Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion
por: Andreasson, Anders S.I., et al.
Publicado: (2017) -
The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion
por: Andreasson, Anders S.I., et al.
Publicado: (2017) -
Ten year follow-up of lung transplantations using initially rejected donor lungs after reconditioning using ex vivo lung perfusion
por: Ghaidan, Haider, et al.
Publicado: (2019)